Provider review
Revel Health review
Shows the first-month price and the standing rate together on every single line.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
We may earn a commission at no extra cost to you. Affiliate partners are listed first on our rankings. How we’re funded.
$199/mo semaglutide standing, $99 first month
Visit Revel HealthFour products, four pairs, no exceptions — the step you would otherwise meet at the second charge.
Price as published
Revel Health
$199/mo semaglutide standing, $99 first month
- Vs median
- $24/mo above the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
The commonest way anyone in this category gets caught out is an introductory price presented as though it were the ongoing one. Revel publishes both, on every line, in the same place: four products, four pairs, no exceptions. That makes the whole catalog readable at a glance, and it is rare enough to be the main reason to look here at all. What the figure buys is stated too — consultation, medication, supplies and shipping — so there is no second bill waiting behind it. The weakness is the ordinary one and it is milder here than most. Each standing rate is introduced as a From price, so it is the bottom of a range whose upper rungs are not published, and if your dose rises you cannot tell from the page what changes. Nothing is said about milligrams anywhere, which means the flat-looking structure cannot be checked against a quantity of drug.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want to see the second-month price before you pay the first
- You want consultation, medication, supplies and shipping inside one figure
- You are comparing several products from one provider on the same basis
Look elsewhere if
- You want to know what a higher dose costs. Only the entry rate is published
- You want the introductory rate to last longer than a month
- You want a dose behind the number
What it actually costs
Price as published
$199/mo semaglutide standing, $99 first month
- Vs median
- $24/mo above the $175 median across the 299 of 548 programs here that publish a plain monthly rate
- Market
- $59–$1,300/mo is the full published spread on this site
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
235 of the 548 programs here price a small dose this way. The introductory price and the standing rate sit together on every line, all four products, no exceptions. The commonest way a buyer is caught out is an intro rate presented as the ongoing one, and this catalog removes that failure entirely. No low-dose product exists and no dose is published, and each standing rate is a floor with nothing published above it, so what happens as the dose rises is still unknown.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not confirmed
- Labs
- Not required
- Pricing
- Check plan terms
What it does well
- Shows the introductory price and the standing rate together on every product.
- Consultation, medication, supplies and shipping are all named as included.
- Four lines priced the same consistent way, so the catalog is comparable within itself.
Pharmacy, labs and oversight
Revel Health does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
2 of 4 published openly
What Revel Health publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere on its own pages.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
The single commonest way a reader in this category is caught out is an introductory price presented as if it were the ongoing one. Revel publishes both, on every line, in the same place — four products, four pairs, no exceptions. That makes the whole catalog readable at a glance in a way that is rare enough to be the main reason to consider it. What it buys is stated too: consultation, medication, supplies and shipping in the figure. The weakness is the usual one and it is milder than most. Each standing rate is introduced as a From price, so it is the bottom of a range whose upper rungs are not published, and a reader at a higher dose cannot tell from the page what changes. Nothing is said about milligrams anywhere.
The honest cons
Every standing rate is a floor with no rung above it published.
- No milligram appears against any figure.
- The introductory rate applies to one month only, on all four lines.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Revel Health is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.
Also consider
Two more programs that price a small dose the way Revel Health does. Both are partners: we may earn a commission if you start care through these links.
Partner
Peter MD
$149/mo GLP1+B12 · $249/mo tirz (quarterly)
Standard plan, self-directed low dose
Partner
Willow
From $299/mo covering all four formats, none priced separately
Standard plan, self-directed low dose
Where this sits
#308 of 548
Ordered with the companies that pay us first, and Revel Health is not one of them. A disclosed partition, not a score.
Compare all 548 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What microdosing GLP-1 costs
- Low dose vs full dose
- The true annual cost of a plan
- What a flat price costs at a low dose
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
HealthRX
$190/mo sema · $239/mo tirz (monthly plan)
- Vs median
- $15/mo above the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the HealthRX review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.